Clinical Trial Update: Enoxaparin Versus Unfractionated Heparin in Subjects Who Present to the Emergency Department With Acute Coronary Syndrome (RESCUE) [Phase 4]

View source ↗

Summary

This update covers the Phase 4 RESCUE trial comparing enoxaparin with unfractionated heparin in emergency department patients with acute coronary syndrome; the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome

Drugs mentioned

• Heparin (unfractionated heparin)
• Lovenox (enoxaparin)

Snippet

Sponsor: Sanofi | Conditions: Acute Coronary Syndrome | Phase 4 | Status: COMPLETED